Ziegler Capital Management’s Health Catalyst HCAT Stock Holding History

Ziegler Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-198,480	Closed	-$1.93M	–	409
2022 Q3	$1.93M	Buy	198,480 +1,785	+0.9%	+$23.6K	0.08%	206
2022 Q2	$2.85M	Buy	196,695 +2,041	+1%	+$34.8K	0.12%	196
2022 Q1	$5.09M	Sell	194,654 -20,576	-10%	-$584K	0.22%	154
2021 Q4	$8.53M	Sell	215,230 -5,530	-3%	-$252K	0.31%	117
2021 Q3	$11M	Buy	220,760 +134,725	+157%	+$7.35M	0.4%	95
2021 Q2	$12.4M	Sell	86,035 -143,498	-63%	-$7.64M	0.41%	84
2021 Q1	$10.7M	Sell	229,533 -3,845	-2%	-$186K	0.34%	113
2020 Q4	$10.2M	Buy	233,378 +9,539	+4%	+$352K	0.34%	107
2020 Q3	$8.19M	Sell	223,839 -6,812	-3%	-$231K	0.32%	100
2020 Q2	$6.73M	Buy	+230,651	New	+$6.37M	0.21%	157

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ziegler Capital Management's HCAT Position: Q4 2022 in Review

Ziegler Capital Management sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 198,480 shares — an estimated $1.93M sold.

Ziegler Capital Management first reported a position in HCAT in Q2 2020 and held it in 10 quarters. The position peaked at $12.4M in Q2 2021. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

Ziegler Capital Management reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
Ziegler Capital Management sold 198,480 Health Catalyst shares in Q4 2022, an estimated $1.93M.
Ziegler Capital Management first reported a position in Health Catalyst in Q2 2020 and held it in 10 quarters.
Ziegler Capital Management's Health Catalyst position peaked at $12.4M in Q2 2021.
166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Ziegler Capital Management's 13F filing for Q4 2022, filed 24 Jan 2023.